Tag: BEPO
Medincell to Present Data Showing Improved Potential of a Monoclonal Antibody Against Melanoma Tumors Using BEPO® Technology – 07/01/2024 at 5:45 p.m.
[ad_1] Medincell will present its R&D advances based on its long-acting injectable technologies at the CRS 2024 conference, taking place July 8-12 in Bologna, Italy, including: • Oncology: presentation of…